STAGE IIIC BREAST CANCER AJCC V7
Clinical trials for STAGE IIIC BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIC BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for hard-to-treat cancers? drug targets gene glitches in advanced tumors
Disease control OngoingThis phase 2 study tests the drug pembrolizumab in 21 people with advanced solid tumors that have specific gene changes (BRCA1, BRCA2, POLE, or POLD1). The goal is to see if the drug can shrink or stop the cancer from growing. This is not a cure, but a way to control the disease.
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
Lifestyle makeover may boost breast cancer treatment
Disease control OngoingThis study tests whether a program of diet, exercise, stress management, and social support can improve outcomes for women with stage II or III breast cancer undergoing radiation therapy. About 110 participants will be randomly assigned to the lifestyle program or usual care. Res…
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Could 3 weeks of radiation be as good as 5? new trial aims to cut arm swelling
Symptom relief OngoingThis study compares a 3-week radiation schedule to the standard 5-week schedule for breast cancer patients who need radiation to the lymph nodes. The goal is to see if the shorter treatment works just as well to prevent cancer from coming back, while causing less arm swelling and…
Matched conditions: STAGE IIIC BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC